CRI Appoints Dr. Aiman Shalabi as Chief Medical Officer to Accelerate Precision Immunotherapy Clinical Collaborations Nonprofit Cancer Research Institute appoints pharmaceutical executive to lead its clinical research program April 17, 2017July 13, 2022
BMS, Parker Institute, and CRI Team Up to Advance Immunotherapy Trials An innovative collaboration model designed to accelerate next-generation precision cancer immunotherapy through network of leading research centers... March 28, 2017July 13, 2022
CRI Awards Grant to Develop Powerful Genomic Data Resource CRI iAtlas to provide immune bioinformatics tool that aims to improve cancer immunotherapy research and drug effectiveness. January 31, 2017July 13, 2022
CRI Partners with FCF in Rare Liver Cancer Research The two nonprofits partnered to support four scientists whose research is focused on developing immunotherapies for patients... December 6, 2016July 13, 2022
Parker Institute for Cancer Immunotherapy and Cancer Research Institute Launch Collaboration on Cancer Neoantigens Researchers at 30 organizations to test algorithms that predict tumor markers from DNA in hunt for new... December 1, 2016July 13, 2022
Cancer Research Institute Joins the Revlon LOVE IS ON 2016 Million Dollar Challenge on CrowdRise Help CRI win the $1 million grand prize. September 12, 2016July 13, 2022
